In 2024, the forecasted import value of pacemakers for stimulating heart muscles to the US is expected to be $769.76 million. This is slightly down from 2023, where the actual import value stood at about $770.32 million. From 2024 to 2028, the import value is predicted to decrease marginally each year. Year-on-year variations show small declines, with the five-year CAGR indicating a slow contraction of the market. Specifically, the import value will see a projected decline of approximately 0.28% per year.
Future trends to watch for include advancements in pacemaker technology that may lead to increased efficiency and potentially lower costs. Additionally, shifts in healthcare policies and the increasing aging population in the US could influence demand patterns for pacemakers, potentially impacting import volumes and values.
